NuvaHealth Tirzepatide Review: Cost & Honest Verdict (2026)

NuvaHealth's site rate-limited this review's verification attempt, so its LegitScript claim couldn't be independently reconfirmed this check. Its $139 first-month semaglutide price is among the cheapest documented on this site, but the standard ongoing price is gated behind checkout. Every fact here comes from the company's own published program.

A rate-limited verification attempt

This review attempted to independently verify NuvaHealth's LegitScript claim directly, but the site returned a rate-limit response rather than page content — the claim is presented here rather than this check.

What NuvaHealth is

NuvaHealth (nuvahealth.org) is a compounded GLP-1 telehealth platform, offering compounded semaglutide and tirzepatide with free, fast delivery and 24/7 patient support. Its Newark, DE address suggests a US-incorporated entity rather than an offshore operation.

What NuvaHealth costs

The first-month price is $139 for compounded semaglutide — among the cheapest in the US compounded telehealth market — and $229 for compounded tirzepatide, sitting in the lower-median range. The standard ongoing monthly price isn't publicly disclosed; it's gated behind checkout.

The brand-vs-compounded question

NuvaHealth dispenses compounded tirzepatide, not the FDA-approved branded product. Compounded tirzepatide is pharmacy-made, not itself an FDA-approved finished drug, and was not the specific product studied in the pivotal trials. See our guide to whether compounded tirzepatide is still legal in 2026 for the regulatory picture.

How the care model holds up

NuvaHealth's real strengths is an aggressive first-month price for semaglutide, free and fast delivery with 24/7 support, and a US-incorporated address (Newark, DE). The trade-offs are significant: the standard ongoing monthly price isn't publicly disclosed, the specific legal entity name and state of incorporation aren't published on the home page — a real transparency gap, pharmacy partners aren't named, per-state availability isn't enumerated, and lab work or coaching support isn't disclosed. This review's own LegitScript verification attempt was also blocked by a rate limit, so treat that claim as rather than freshly confirmed. As with any GLP-1 program, ask directly for your maintenance-dose price before committing; tirzepatide carries labeled warnings for acute pancreatitis, gallbladder disease, and a boxed thyroid C-cell tumor warning — see our guides on Zepbound side effects, the gallbladder risk, and the thyroid cancer warning.

Does the drug work? (Separate from the provider)

Judge the provider on price, oversight and disclosure; judge the molecule on its trials. Tirzepatide's are strong — roughly 15–21% of body weight over 72 weeks in SURMOUNT-1¹, and better than semaglutide head-to-head² — but they were run on the brand drug at FDA-approved doses. Our tirzepatide evidence guide has the full picture.

The honest verdict

NuvaHealth's aggressive first-month price is a real hook, but the ongoing price is gated, the legal entity isn't named, and this review couldn't independently reconfirm its LegitScript claim due to a rate limit. Ask for the maintenance-dose price in writing before committing. For a provider with a genuinely reconfirmed LegitScript seal and fully published pricing, compare it against NuuVim or NewSelf. See our best tirzepatide providers ranking for the full field.